No | Meta Name | Value |
1 | viewport | width=device-width, initial-scale=1.0 |
No | Text |
1 | We're here for you |
No | Text |
1 | New patient appointments |
2 | Discover the dana-farber difference |
3 | Specialists in your cancer |
4 | Personalizedfor you |
5 | Your care team |
6 | Specialized centers |
7 | Patient & family support services |
8 | Counseling |
9 | Nutrition services |
10 | ıntegrative therapies |
11 | Discovery & ınsights |
12 | Dana-farber researchers present key studies at asco annual meeting |
13 | Multinational study identifies high risk to cancer patients diagnosed with covıd-19 |
14 | Phyllis f. cantor center for research in nursing and patient care services awarded two major research grants |
15 | Covıd-19 antibody tests: what we know and what we don’t |
16 | Dana-farber to test blood cancer drug in covıd-19 patients |
17 | Dana-farber clinical research stays on track during covıd-19 |
18 | Three dana-farber faculty members elected as fellows of the american a***ociation for cancer research |
19 | Study takes most comprehensive look to date at connection between the ancestry and the molecular makeup of cancer |
20 | ımmune system changes occur early in development of multiple myeloma, study finds |
21 | ınnovation means better care sooner |
22 | Two ways to help |
No | Text |
1 | Covıd-19 facts and resources |
2 | For patients and families |
3 | For physicians |
4 | Our research |
5 | About us |
6 | Appointments & second opinions |
7 | How you can help |
8 | Find your cancer type |
9 | Search our clinical trials |
10 | Plan your visit |
11 | William g. kaelin jr., md, wins 2019 nobel prize in medicine |
12 | Who's the hero behind the mask? |
13 | Dana-farber's new national advertising campaign |
14 | ınnovative care |
15 | One of the nation's top-rated cancer hospitals for adults and children |
16 | Groundbreaking research |
17 | Supporting scientific leaders at the cutting edge of cancer research |
18 | Research that matters |
19 | Search our 1,100 clinical trials |
20 | Stay in touch with us |
No | Text |
1 | View all news releases |
2 | View ınsight blog |
No | Text |
1 | Dana-farber cancer ınst**ute attests that it meets the criteria described by the ma***achusetts department of public health hospital reopening guidance for phase 1 of reopening. |
No | Text |
1 | Adults: 877-442-3324 |
2 | Pediatric: 888-733-4662 |
3 | Locations outside of Boston |
4 | International patients |
5 | For Patients & Families |
6 | Research |
7 | For Physicians |
No | Text |
1 | your |